Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01560845
What this trial is testing

ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis

Who this might be right for
Liver CirrhosisPortal HypertensionHepatic Decompensation+1 more
Wenzhou Medical University 50
Early research (Phase 1)Study completedNCT02038972
What this trial is testing

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

Who this might be right for
Sensorineural Hearing Loss
James Baumgartner, MD 11
Testing effectiveness (Phase 2)Study completedNCT03473301
What this trial is testing

UCB and MSCs in Children With CP: ACCeNT-CP

Who this might be right for
Cerebral Palsy
Joanne Kurtzberg, MD 91
Testing effectiveness (Phase 2)Study completedNCT02192749
What this trial is testing

Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism

Who this might be right for
Autism
Translational Biosciences 20
Testing effectiveness (Phase 2)Study completedNCT00314106
What this trial is testing

Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
National Cancer Institute (NCI) 26
Early research (Phase 1)WithdrawnNCT00062543
What this trial is testing

Hepatic Artery Infusion of CD34+ Cells

Who this might be right for
Stem Cell TransplantationLiver Diseases
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00423124
What this trial is testing

Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies

Who this might be right for
Hematological Malignancies
AGC Biologics S.p.A. 57
Testing effectiveness (Phase 2)Study completedNCT03004976
What this trial is testing

Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke

Who this might be right for
StrokeStroke, AcuteBrain Injury, Acute
Joanne Kurtzberg, MD 79
Testing effectiveness (Phase 2)Study completedNCT01131169
What this trial is testing

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT02337595
What this trial is testing

Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation

Who this might be right for
Precursor T-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteImmune Deficiency Disease+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Early research (Phase 1)Not Yet RecruitingNCT07796061
What this trial is testing

Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)

Who this might be right for
Pontine Diffuse Midline GliomaDiffuse Intrinsic Pontine GliomaThalamic Diffuse Midline Glioma
Children's National Research Institute 45
Testing effectiveness (Phase 2)Study completedNCT00923910
What this trial is testing

Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

Who this might be right for
Leukemia, Acute Myelogenous (AML)Leukemia, Acute Lymphocytic (ALL)Leukemia, Chronic Myelogenous (CML)+2 more
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Study completedNCT00366145
What this trial is testing

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Graft Versus Host Disease
Mesoblast, Inc. 260
Early research (Phase 1)UnknownNCT04914403
What this trial is testing

Mesenchymal Stem Cells for The Treatment of Frailty Syndrome

Who this might be right for
Frailty Syndrome
Meridigen Biotech Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT02985775
What this trial is testing

Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation

Who this might be right for
CMV Infection
Peking University People's Hospital 41
Testing effectiveness (Phase 2)UnknownNCT04623606
What this trial is testing

Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones

Who this might be right for
Osteogenesis Imperfecta
Christian Medical College, Vellore, India 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03597321
What this trial is testing

Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 124
Testing effectiveness (Phase 2)Study completedNCT00429416
What this trial is testing

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)Study completedNCT00987987
What this trial is testing

Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion

Who this might be right for
Hematologic NeoplasmsRelapse
Assistance Publique - Hôpitaux de Paris 21
Testing effectiveness (Phase 2)Study completedNCT02439398
What this trial is testing

Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI

Who this might be right for
Acute Myocardial Infarction
Coretherapix 55
Next Page